Interesting Endo: Drug Trials & Cardio Health

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.Abstract Link.****Low Testosterone - a Risk Marker Rather than a Risk Factor for Type 2 Diabetes.Abstract link.

Association of Plasma DPP4 Activity with Mild Cognitive Impairment in Elderly Patients with Type 2 Diabetes: Results from the GDMD Study in China. Abstract link.****Consumption of Meals Prepared at Home and Risk of Type 2 Diabetes: An Analysis of Two Prospective Cohort Studies. Abstract link.

An Extra 1,000 Steps Per Day Relates to Improved Cardiovascular Health in Children with Type 1 Diabetes. Abstract link. **** Long-term Cognitive Implications of Intrauterine Hyperglycemia in Adolescent Offspring of Women with Type 1 Diabetes (the EPICOM Study). Abstract link.

Long-Term Excess Mortality Associated with Diabetes Following Acute Myocardial Infarction: a Population-Based Cohort Study. Abstract Link. ****Diabetes, Kidney Disease, and Cardiovascular Outcomes in the Jackson Heart Study. Abstract Link.

FDA Approves AspireAssist Obesity Device. Press release. ****FDA Advisory Committee Recommends Approval of Jardiance® (empagliflozin) for Cardiovascular Indication in 12-11 Vote. Press release.

Primary Prevention of Sexual Dysfunction with Mediterranean Diet in Type 2 Diabetes: The MÈDITA Randomized Trial. Abstract link.****Plant-Based Dietary Patterns and Incidence of Type 2 Diabetes in US Men and Women: Results from Three Prospective Cohort Studies. Abstract link.

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. Abstract link.****Increased Risk of Incident Chronic Kidney Disease, Cardiovascular Disease, and Mortality in Diabetic Patients with Comorbid Depression. Abstract link.

Early Childhood Obesity: Association with Healthcare Expenditure in Australia. Abstract link. ****Obesity and Associated Adverse Health Outcomes Among US Military Members and Veterans: Findings from the Millennium Cohort Study. Abstract Link.